Jane Street Group LLC trimmed its holdings in Inogen, Inc. (NASDAQ:INGN – Free Report) by 83.1% during the third quarter, ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...

Goleta-based Inogen, a medical technology specializing in the manufacturing of portable oxygen containers, announced Dec. 30 that it had received U.S. Food and Drug Administration clearance for the ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for ...

StockNews.com cut shares of Inogen (NASDAQ:INGN – Free Report) from a buy rating to a hold rating in a research note published on Friday. Separately, Needham & Company LLC reaffirmed a “hold” rating ...

Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...

Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog. Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which ...

Inogen, Inc. (NASDAQ: INGN) is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

Inogen said regulators have cleared its SIMEOX 200 Airway Clearance Device to be used by U.S. patients with chronic respiratory diseases. The medical technology company said Monday that the Food ...